Physician Growth Partners Advises Urology Austin in Establishing National Partnership to Form Urology America
Nov 12, 2020
November 12, 2020 - /PressAdvantage/ - Physician Growth Partners (PGP) is pleased to have represented Urology Austin and its affiliated businesses (collectively “UA” or the “Company”) in establishing a partnership to form Urology America to develop a national, best in class urology platform.
UA was established in 2003 through the strategic combination of three premier independent urology practices in the greater Austin market. The Company grew to dominate the market and solidified itself as the top-quality urologic care provider and a nationally recognized clinical thought leader.
Twenty-three shareholders lead UA’s clinical operations. This includes management of the various service lines, including comprehensive medical and surgical urology, a state-of-the-art radiation oncology center, a full-service pathology lab, and an in-house pharmacy, among other ancillary services. UA’s clinical network exceeds 50 providers across more than 20 locations, with more than 250 support staff across the business.
PGP served as the exclusive advisor to Urology Austin, as they evaluated strategic alternatives and consummated a new partnership to form Urology America, with the goal of developing the leading national urological platform centered around cutting-edge clinical care.
Speaking on the transaction process, Patrick Murphy, former CEO of Urology Austin, commented, “Our entire process with PGP has been outstanding. I’ve worked with countless advisors over my almost 30 years in healthcare on M&A partnerships, and never has one been so involved as Michael and the PGP team. What impressed me the most was their interest in learning our business from top to bottom to ensure everything was covered properly throughout the deal. They were with us every step of the way from beginning to end. Their diligence and assistance in navigating through the issues gave us the assurance the outcome we achieved was a success.”
Michael Kroin, Managing Partner of Physician Growth Partners, added, “PGP is incredibly pleased with the outcome we achieved alongside UA. The shareholders had the preeminent regional platform and were ready to replicate it at the national level. The Company’s trust in PGP allowed us to both work quickly and get creative to meet Urology Austin’s goals and succession plans. The formation of Urology America in developing a national platform while maintaining clinical excellence is what the shareholders and management team of UA were seeking when we set out on this process. We look forward to seeing the platform grow into the leader they aspire to be.”
The newly formed Urology America platform is focused on growing both organically and through partnerships with other leading independent urology groups across the country that share their dedication to exceptional clinical care and progressive thought leadership within Urology.
About Physician Growth Partners
Physician Growth Partners is a boutique healthcare service platform dedicated to advising physician practices in transactions with private equity. They create value by providing operational support, strategic positioning, and transaction advisory, ultimately realizing an optimal outcome for their clients. You can find additional press releases here.
For more information about Physician Growth Partners, please contact the company.
###
For more information about Physician Growth Partners, contact the company here:
Physician Growth Partners
Michael Kroin
630 - 299 - 6260
[email protected]
222 W Ontario St Ste. 315, Chicago, IL 60654
ReleaseID: 60039475
More News
$57.2 billion Treasury cash drain hits Wall Street this week: Why semiconductor stocks and SMH ETF investors face more volatility, with a bigger liquidity test coming in 2027
Upcoming Treasury bill settlements on November 10 and 12 are expected to withdraw $57.2 billion from markets. The VanEck Semiconductor ETF has already experienced a notable decline since October, losing nearly 25 percent of its value. Historical trading data indicates that semiconductor stocks perform better when Treasury bill issuance is lower. A potential easing of liquidity pressure may occur in December due to reduced auction sizes.
Between the chip and the slip: Honeytrap suspicions further sours ties between US and China
Nvidia's CEO Jensen Huang is being investigated for having an alleged affair with a potential Chinese intelligence agent. This individual reportedly sought to gather information about Nvidia's advanced technology. Nvidia's board has launched an independent probe to examine the allegations against Huang. US lawmakers are demanding a briefing on the matter amid heightened concerns over national security.
Russia-Ukraine peace talks: In Abu Dhabi, US to look for security guarantees for both
The talks follow last month's localized truce around the Russian-occupied city of Oleshky in southern Ukraine that was brokered with the help of US first lady Melania Trump and allowed the evacuation of some of its residents and the delivery of desperately needed humanitarian supplies.
Ozempic Zepbound eye risk warnings: Diabetes, weight-loss drugs Novo Nordisk's Ozempic, Wegovy, Eli Lilly's Mounjaro, Zepbound pose potential threat to eye, sudden vision loss, warns US FDA
Eli Lilly's Mounjaro and Zepbound and Novo Nordisk's Ozempic and Wegovy were under scanner of United States Food and Drug Administration (US FDA).
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.